Lyrica Cr

Product manufactured by U.s. Pharmaceuticals

Application Nr Approved Date Route Status External Links
NDA209501 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Lyrica Cr Is Indicated For The Management Of: Neuropathic Pain Associated With Diabetic Peripheral Neuropathy Postherpetic Neuralgia Efficacy Of Lyrica Cr Has Not Been Established For The Management Of Fibromyalgia Or As Adjunctive Therapy For Adult Patients With Partial Onset Seizures. Lyrica Cr Is Indicated For The Management Of: Neuropathic Pain Associated With Diabetic Peripheral Neuropathy (Dpn) ( 1 ) Postherpetic Neuralgia (Phn) ( 1 ) Efficacy Of Lyrica Cr Has Not Been Established For The Management Of Fibromyalgia Or As Adjunctive Therapy For Adult Patients With Partial Onset Seizures.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Pregabalin PREGABALIN ZINC5152

Comments